Have you evaluated the performance of Charles River Laboratories' (CRL) international operations during the quarter that concluded in September 2025? Considering the extensive worldwide presence of ...

Charles River Laboratories International Inc CRL reported Q1 sales of $1.03 billion, an increase of 12.6% Y/Y, beating the consensus of $986.35 million. The company reported adjusted EPS of $2.78, ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ...

Charles River Laboratories achieved only 6.5% organic revenue growth in FY23 due to weakness in the broader life science industry. CRL offers a comprehensive range of services to pharmaceutical and ...

The life sciences tools and services industry is projected to grow at the rate of 10.8% per year into 2030, driven by advancements in gene sequencing, chromatography, and AI. Charles River ...

Get the latest news on Charles River stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Charles River performance ...

Detailed price information for Charles River Laboratories Intl (CRL-N) from The Globe and Mail including charting and trades.